Blomberg Jensen, Martin http://orcid.org/0000-0003-3800-4253
Andreassen, Christine Hjorth http://orcid.org/0000-0002-3643-6426
Jørgensen, Anne http://orcid.org/0000-0002-6409-198X
Nielsen, John Erik
Juel Mortensen, Li
Boisen, Ida Marie
Schwarz, Peter http://orcid.org/0000-0002-0483-8594
Toppari, Jorma
Baron, Roland http://orcid.org/0000-0001-5784-5934
Lanske, Beate
Juul, Anders
Funding for this research was provided by:
Rigshospitalet
Kræftens Bekæmpelse
Novo Nordisk Fonden
Sundhed og Sygdom, Det Frie Forskningsråd
Article History
Received: 29 October 2019
Accepted: 23 March 2021
First Online: 23 April 2021
Competing interests
: All authors declare no competing interests except for M.B.J. who holds two patents on the use of RANKL inhibitors to treat male infertility. R.B. has been on the advisory Board of Amgen and B.L. is now employed by Radius Health. All other authors state no conflicts of interest.